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BUWALDA, B., C. NYAKAS, J. M. KOOLHAAS, P. G. M. LUITEN AND B. BOHUS. Vasopressin prolongs behavioral nd 
cardiac responses to mild stress in young but not in aged rats. PHYSIOL BEHAV 52(6) 1127-1131, 992.--In young male Wistar 
rats sudden silence superimposed on low intensity background noise vokes arelative decrease inheart rate. This bradycardia is 
accompanied byimmobility behavior. In the present study, involving young (3 month), late-adult (14 month), aged (20 month), 
and senescent (25 month) rats the magnitude ofthe stress-induced bradycardia shows an age-related reduction while the behavioral 
immobility response r mained unchanged during the process of aging. Arginine-8-vasopressin (AVP, 6 #g/kg SC) administered 
60 rain prior to the experiment led to a prolonged behavioral nd cardiac stress response inyoung and late-adult rats, but not in 
aged and senescent animals. The peripheral nd central mechanisms possibly involved in the failure of systemically applied AVP 
to improve bradycardiac stress responses in aged rats are discussed. 
Aging Immobility behavior Autonomic responses Bradycardia Stress Vasopressin 
THE neurohypophyseal peptide arginine-8-vasopressin (AVP) 
modifies various forms of learned behavior, apart from its well- 
known classical endocrinological actions. Several studies howed 
that both systemically and centrally administered AVP prolongs 
extinction and improves consolidation and retrieval processes 
in avoidance l arning tasks (10,19,23,25,37). A number of studies 
have focussed on the effects of AVP on physiological responses 
related to emotion and behavioral daptation (4,5,20). Experi- 
ments in freely behaving adult rats in various tressful situations 
showed that AVP serves as an important modulator of a bra- 
dycardiac response to an emotional stressor (4,20). Because this 
stress-induced bradycardia appears to be vagally mediated (8), 
these experiments suggest that AVP is involved in a neural net- 
work that serves a parasympatheticaUy regulated response to 
stress. 
Previous research in this laboratory focussed on the age-re- 
lated changes in the autonomic responses due to stressors in- 
ducing behavioral immobility (30). During this passive way of 
coping, young male Wistar rats reacted predominantly with a 
vagaUy mediated cardioinhibitory response. While the behavioral 
responsiveness to tress remained intact, the initial bradycardiac 
response appeared to be diminished in aged rats (30). Therefore, 
an age-related attenuation f parasympathetic control of cardiac 
functioning during emotional stress ituations was suggested (30). 
Peripherally applied AVP appeared to reinstate the bradycardiac 
response to a conditioned stress of fear of inescapable footshock 
in 14-month-old male Wistar rats (5,29). These results led to 
the hypothesis that AVP-dependent mechanisms are involved 
in the age-related reduction of stress-induced parasympathetic 
responsiveness. Because the bradycardiac response to condi- 
tioned aversive stimuli s thought o reflect the attentional de- 
mands of the experimental situation (31), one would expect a 
comparable action of AVP in nonaversive conditions that result 
in vagal activation due to acute orientation/attention behavior. 
Sudden silence superimposed onlow intensity background noise 
is eliciting bradycardia and immediate behavioral rrest in young 
rats (18). In a previous tudy, AVP was demonstrated to enhance 
behavioral nd cardiac responses tothis sudden silence stress in 
young male rats, whereas it failed to improve or even worsened 
such responses in 24-month-old rats (7). 
The aim of this paper was to analyze the modulating prop- 
erties of AVP on behavioral nd cardiac responses to the mild 
stress of sudden silence not only in young and old rats, but also 
in rats of intermediate ages to study at which moment a hypo- 
sensitivity to vasopressinergic modulation of stress-related be- 
havior and cardiac ontrol develops during the process of aging. 
METHOD 
Animals and Housing 
Male Wistar ats of four different ages were used. The animals 
were 4, 14, 20, and 25 months old and originated from the 
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Winkelman substrain (kindly donated by Troponwerkc, Col- 
ogne, Germany). They were housed six to a cage (40 × 60 X 15 
cm), with food and water ad lib, in a temperature-controlled 
environment of 21 _+ 2°C: the lights were on from 0730 to 1930 
h. All experiments were performed between 0900 to 1300 h. 
Surgeo" 
In order to record the electrocardiogram (ECG), transcuta- 
neous stainless teel electrodes made of standard paperclips were 
implanted under light ether anesthesia. One electrode was placed 
between the scapulae and the other in the midback region, ac- 
cording to the method described previously (3). At least 3 days 
were allowed for recovery before the start of the experiment. 
Recording and Analysis of the ECG 
The ECG of freely moving rats was monitored telemetrically 
by means of a miniature FM transmitter (model SNR 102F, 
Dynamic Electronics Ltd., London, England) as described before 
(3). The transmitter was attached to a velcrose strap secured 
around the chest of the rat and connected to the transcutaneous 
electrodes. The transmitted signals were received on a com- 
mercial FM receiver, amplified (Narco Bio-System Inc. Mod. 
FM-1100-7), and stored on tape by a commercial tape recorder. 
During recording and analysis, the quality of the ECG signal 
was continuously monitored on an oscilloscope. 
Recorded ECG samples were played back through a cardio- 
tachometer pulsegenerator (Schmitt-trigger) that generated a
square wave pulse at each R wave. The interbeat interval (IBI), 
i.e., the time elapsed between onset of the two consecutive pulses, 
was measured using a personal computer (Olivetti M24). The 
mean IBis were computed for periods of 55 s. IBis shorter than 
100 and longer than 220 ms were discarded because these were 
likely to be due to artifacts. 
Procedure 
The behavioral and cardiac responses to a sudden drop in 
background noise were measured in a rectangular clear Plexiglas 
cage (85 × 60 × 60 cm), designated as an open field in this 
paper. This open field with a wood shavings covered floor was 
located in an acoustically isolated experimental room where a 
noise generator produced a background noise that was main- 
tained at a constant level (65 dB, 2-8 kHz). Upon entering, a 
velcro strap holding a miniature FM-transmitter for the ECG 
recordings was fixed around the chest of the rat. The animal was 
placed in the open field for 5 min on day 1. On day 2, the test 
day, the animals were exposed again to the open field for 5 min. 
After 2 min the background noise was switched off, leaving the 
animal in almost total silence for the remaining 3 min. Heart 
rate and behavior were recorded for three periods (P) of 60 s. 
Second-min recordings were made during the 60 s immediately 
prior to switching off the background noise (P1). Third-min re- 
cordings (P2) during the 60 s immediately after switching off 
the noise (P2) and fifth-min recordings (P3) were regarded, re- 
spectively, as response and recovery measurements. As a be- 
havioral measure, the time spent immobile was determined by 
an observer during the three periods. Immobility was defined as 
almost motionless scanning of the environment with only minor 
head movements. 
Treatment 
Arginine-vasopressin (AVP) was dissolved in saline and in- 
jected subcutaneously (SC) in a dosage of 6 ~g/kg/ml 60 min 
prior to the exposure to the open field. Saline injections erved 
as vehicle. The selection of the single dose of the peptide was 
based on the results of the previous studies of }oLlng and aged 
rats' cardiac response to emotional stress (29) and on several 
other studies describing behavioral and physiological effects of 
peripherally applied AVP (20-22,24,25). EEG recordings (I 3) 
further indicated a similarity between SC administered AVP in 
a dose of 6 ug/kg and a behaviorally relevant intracerebroven- 
tricular administered ose of 1 ng. The rats were iniccted m a 
crossover design with saline or AVP, each animal serving as its 
own control. A 7-day wash-out period was allowed between in- 
jections to minimize interaction of treatments. 
Slatistic.~ 
]he  results are presented as means ± SEM in two measures; 
absolute values are presented in the figures and response (P2- 
PI) and recovery (P2-P3) values in the table. The absolute car- 
diac data were analyzed using a multivariate ANOVA (two-way) 
utilizing one between-subjects factor (group) and one repeated 
measures within-subjects factor (periods), a two-tailed Student's 
t-test and a paired t-test. Response and recovery values were 
analyzed using a one-way ANOVA utilizing the factor age. Be- 
havioral data were evaluated for significance using the Kruskal- 
Wallis ANOVA and the Wilcoxon matched-pairs anked-signs 
test. A probability level o fp  < 0.05 was taken as statistical sig- 
nificance for all tests. 
RESULTS 
Vasopressinergic Modulation of Cardiac Stress Responses 
Figure 1 shows the heart rate values, expressed as IB1, of the 
animals in the open field and the cardiac response to stress of 
sudden silence. ANOVA testing revealed no effect of age on 
presilence, i.e., prestress values during PI. The magnitude of 
response as well as the recovery, values after sudden cessation of 
background noise are presented in Table 1. Multivariate ANOVA 
with repeated measures for the three periods showed no signif- 
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FIG. I. Heart rate expressed as interbeat interval (IBI) during a 5-min 
exposure to an open field before and after sudden reduction of a non- 
aversive background mixed noise, measured in 4 (n = 9), 14 (n = 9), 20 
(n = 8) and 25 (n = I l)-month-old male Wistar ats. One-min recordings 
were made during the second min of exposure to the open field with the 
noise on (Pl); during the third min immediately after the noise was 
switched off (P2), and during the fifth rain (P3). IBis are presented after 
subcutaneous administration of saline (open circles) and AVP (closed 
circles). Means +_ SE are shown. 
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interaction between age and periods, F(2, 64) = 4.7, p = 0.0007. 
Although all vehicle-treated age groups showed a significant car- 
dioinhibitory response, i.e., an increase in IBI, to switching off 
the noise, the magnitude of this response (see Table 1) showed 
an age-related decrease, F(3, 32) = 6.27, p = 0.002. Recovery, 
measured as the difference in IBI between P3 and P2 was also 
reduced in aging, F(3, 32) = 6.73, p = 0.002. 
Administration of AVP caused adecrease in heart rate already 
before the reduction of background noise, i.e., P1, in the open 
field in all age groups, expressed in a significant treatment effect, 
F(1, 65) = 21.7, p < 0.001. There was no significant interaction 
between age and treatment on prestress values. Multivariate 
ANOVA for the factors age by treatment by periods also showed 
no significance. The interaction between age and periods as 
shown after vehicle treatment disappeared after AVP adminis- 
tration, suggesting an effect of the treatment throughout the pe- 
riods. This is caused by the absence of recovery during P3 of 
the cardiac stress response in 4- and 14-month-old rats receiving 
AVP. A significant interaction between treatment and periods 
was observed in 4-, F(2, 32) = 5.88, p = 0.007, and 14-month- 
old rats, F(2, 32) = 3.17, p = 0.05. Twenty- and 25-month-old 
rats failed to show this interaction. 
Vasopressinergic Modulation of Behavioral Stress Responses 
ANOVA testing revealed no significant age or treatment effect 
on prestress immobility values. Neither was an interaction be- 
tween age and treatment present during P 1. Figure 2 shows that 
all vehicle-treated animals responded to sudden cessation of 
background noise with an increase in immobility behavior (see 
also Table 1). ANOVA (Kruskal-Wallis) indicated that neither 
the magnitude of the response nor the recovery after the sudden 
stimulus change were affected by age. Only 20-month-old ani- 
mals failed to show a significant recovery of immobility behavior 
after stress. 
After AVP administration there was an effect of age on im- 
mobility responses, H(3, 37) = 14.95, p = 0.002. Post hoc testing 
indicated that in 14-month-old rats AVP increased the immo- 
bility response (p < 0.05), whereas in 25-month-old rats the 
behavioral stress response was reduced (p < 0.01). A two-way 
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FIG. 2. Behavioral immobility in the open field before (PI) and after 
sudden silence (P2 and P3) in 4-, 14-, 20-, and 25-month-old rats. For 
further information see Fig. 1. 
age and treatment on immobility responses, F(3, 65) = 2.8, p 
= 0.04. 
DISCUSSION 
The present findings indicate that between the age of 14 and 
20 months, male Wistar rats develop a hyposensitivity o AVP 
in modifying the behavioral and cardiac response to mild un- 
expected stress. 
AVP caused a reduction in heart rate in all age groups already 
before the sudden reduction of background noise. This may be 
the result ofa baroreceptor reflex-induced vagal activation. That 
this alternative is unlikely is suggested by our former study (29). 
Sixty min after peripheral administration of 10 ~g/kg AVP a 
moderate bradycardia was found in rest conditions, together 
with a slightly decreased blood pressure. Lebrun et al. (24) also 
showed that the systolic pressor esponse to 6 ~tg/kg AVP dis- 
TABLE 1 
RESPONSE VALUES TO (P2-PI) AND RECOVERY AFTER (P2-P3) THE SUDDEN CESSATION 
OF BACKGROUND NOISE AFCER SALINE OR AVP APPLICATION 
Response toSudden Silence Recovery After Sudden Silence 
Rat Age AIBI (ms)  Almmobility (s) AIBI (ms)  Almmobility (s) 
4 Months 
SAL 15.4 + 3.7 26.2 _+ 3.6 14.1 + 3.6 28.0 _+ 6.3 
AVP 18.1 + 4.2 30.3 + 5.4 1.7 + 3.7* 8.7 _+ 6.0t 
14 Months 
SAL 10.0 _+ 1.7 24.9 + 6.1 7.2 + 1.6 14.7 _+ 7.0 
AVP 18.8 + 4.7 37.4 + 4.4 t 0.9 _+ 5.2 6.2 + 5.8 
20 Months 
SAL 4.8 + 1.8 19.0 + 6.2 -2.1 + 4.0 -0.1 + 14.0 
AVP 5.2 + 2.7 13.9 + 5.4 -0.7 + 3.8 -5.0 + 6.2 
25 Months 
SAL 3.5 + 0.9 23.7 + 3.6 2.3 + 1.1 16.4 _+ 4.3 
AVP 6.0 + 3.0 8.7 + 5.0* -1.2 _+ 2.0 0.7 _+ 4.4* 
"1" Within the age group the response and recovery values after AVP administration were 
compared with the animals' own vehicle control value by means of a paired t-test (cardiac 
data) or a Wilcoxon matched pairs-ranked signs test (behavioral data), *p < 0.01, tP < 0.05. 
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appears within 60 min after administration. Therefore, the re- 
duction of heart rate may be caused by a direct action of vaso- 
pressin on the heart (14,35) through effects of the peptide on 
coronary blood flow and oxygen availability within the myo- 
cardium (2,27). 
In addition to the general reduction in heart rate, AVP ex- 
tended the bradycardiac stress response in 4- and 14-month-old 
animals. These data support he finding of an effect of AVP on 
acute cardiac stress responses in young rats as described previ- 
ously (20). 
Administration of AVP enhanced the magnitude of the be- 
havioral immobility response to stress in 14-month-old animals, 
whereas it decreased this response in 25-month-old rats. This 
differential age-related effect of AVP on the behavioral immo- 
bility responses i reflected in the significant interaction between 
age and treatment. Peptide treatment further prolonged the du- 
ration of immobility behavior in 4-month-old animals. 
Both centrally (10) and peripherally (25) located mechanisms 
are hypothesized to be involved in vasopressinergic modulation 
of stress-related autonomic and behavioral responses. The ex- 
tension of the bradycardiac stress responses may reflect a sen- 
sitization of baroreflex control of circulation (16), No data are 
available, however, on age-related changes in the vasopressinergic 
modulation of these reflexes. In numerous studies changes of 
vasopressinergic innervation patterns in the brain of aged rodents 
was shown [for review see (36)]. Age-related changes in vaso- 
pressin cells in the suprachiasmatic nucleus were reported (34). 
Dorsa and Bottemiller (12) found decreased AVP concentrations 
in a number of intra- and extrahypothalamic areas in aged rats, 
e.g., in septum, the vascular organ of the lamina terminalis, and 
the locus coeruleus. A study of Fliers et al. (15) revealed that 
age-related reduction in vasopressinergic innervation occurs in 
many areas of the brain controlling behavioral and autonomic 
responses. Only a few studies have been devoted to the effects 
of exogenous AVP in behavioral tasks in aged animals. While 
the present study addresses the effects of AVP on attentional 
processes, most of these studies involve age-related effects of 
AVP on memory measures. In late-adult rats (13-14-months 
old) AVP enhanced cardiac and behavioral stress responses (5) 
and improved memory function (37). Cooper et al. (9) showed 
that AVP facilitated the conditioned taste aversion in 19- and 
24-month-old rats. 
While the present findings in the younger groups confirm the 
reported effects of AVP on behavioral and autonomic perfor- 
mance (5,20,25), the failure of the peptide to elicit similar effects 
in aged rats indicate a decreased sensitivity to AVP in these old 
animals. A cause of the vasopressinergic hyposensmvity in aged 
rats may be a decreased sensitivity or number of vasopressinergic 
receptors during aging. No information to our knowledge is 
available yet about age-related alterations in the properties of 
vasopressinergic receptors in the brain. Peripherally. however, 
a strong decrease in vasopressin binding was tbund in the kidney 
(33) and the liver (26) of aged rats. Administration ofAVP thiled 
to correct the impaired urine concentration in aged rats (l/. 
indicating the decreased sensitivity of the aged kidney to the 
antidiuretic effect of AVP. However, vascular smooth muscles 
of old rats show an increased sensitivity to AVP (17). Accord- 
ingly, there are probably organ-specific differences in the sen- 
sitivity to vasopressin during aging, i.e., age does not affect all 
vasopressinergic receptors uniformly. A third possible mecha- 
nism of the reduced effect of AVP in aged rats might be related 
to age-dependent changes in receptor-stimulated second-mes- 
senger activation (38). There is extensive vidence that central 
and peripheral catecholaminergic systems interact with neuro- 
peptides uch as AVP in the modulation of behavior (6,23,32). 
Because peripherally applied d-amphetamine enhances the bra- 
dycardiac stress response in aged rats (28), it is also possible that 
AVP indirectly modulates the cardiodecelerato~' response to 
emotional stress through activation of aminergic systems in the 
brain. The failure of AVP to restore the bradycardia in old an- 
imals, therefore, can be related to the reported age-related re- 
duced activation of central catecholaminergic systems (39). 
Whether the effects of systemically applied AVP in affecting 
cognitive processes are peripherally or centrally mediated is still 
an issue of major discussion (11,22). Whereas De Wied and 
collegues (10) suggested a direct central action of vasopressin, 
Le Moal et al. (25) hypothesized that hemodynamic responses 
shortly after the peptide injection were causing the behavioral 
effects of AVP. Koob et al. (21 ) suggested that systemically and 
centrally administered AVP can influence behavior in a ho- 
mologous manner but by different mechanisms of action. Our 
data fit with the decreased peripheral sensitivity, but a central 
direct action cannot be excluded. 
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